...
首页> 外文期刊>Metabolic brain disease >Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.
【24h】

Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.

机译:诊断微小肝性脑病的临界闪烁频率和连续反应时间:对154例肝病患者的比较研究。

获取原文
获取原文并翻译 | 示例

摘要

Minimal hepatic encephalopathy (MHE) is intermittently present in up to 2/3 of patients with chronic liver disease. It impairs their daily living and can be treated. However, there is no consensus on diagnostic criteria except that psychometric methods are required. We compared two easy-to-perform reproducible bedside methods: the critical flicker frequency (CFF) and continuous reaction times (CRT) tests. A CFF <39 Hz and CRT-index <1.9 (index: the ratio 50/(90 minus 10) percentiles of reaction times) indicates cerebral dysfunction. 154 patients with acute or chronic liver disease with out overt hepatic encephalopathy (HE) underwent both tests at the same occasion. Both tests were abnormal in 20% of the patients and both tests were normal in 40% of the patients. In more than 1/3 the two tests were not in agreement as CFF classified 32% and CRT-index classified 48% of the patients as having MHE (p < 0.005). The two tests were weakly linearly correlated (r(2) = 0.14, p < 0.001) and neither test correlated with the metabolic liver function measured by the Galactose Elimination Capacity (GEC), nor with the blood ammonia concentration. Both tests identified a large fraction of the patients as having MHE and cleared only 40%. The two tests did not show concordant results, likely because they describe different aspects of MHE: the CFF gives a measure of astrocytic metabolic state and hence pathogenic aspects of MHE, whereas the CRT measures a composite key performance, viz. the ability of reacting appropriately to a sensory stimulus. The choice of test depends on the information needed in the clinical and scientific care and study of the patients.
机译:慢性肝病患者中,有多达2/3的患者间歇性存在最小的肝性脑病。它损害了他们的日常生活,可以得到治疗。但是,除了需要心理测量方法外,在诊断标准上尚无共识。我们比较了两种易于执行的可重复床边方法:临界闪烁频率(CFF)和连续反应时间(CRT)测试。 CFF <39 Hz和CRT指数<1.9(指数:反应时间的比率50 /(90减去10)百分位数)表示脑功能障碍。 154例没有明显肝性脑病(HE)的急性或慢性肝病患者在同一时间接受了两项检查。两种测试均在20%的患者中均异常,而两种测试均在40%的患者中均正常。在超过1/3的患者中,两项检测不一致,因为CFF将MHE分类为32%,而CRT指数将48%分类为MHE(p <0.005)。两项测试均呈弱线性相关(r(2)= 0.14,p <0.001),且两项测试均与半乳糖消除能力(GEC)测得的代谢肝功能或血氨浓度无关。两项测试均发现大部分患者患有MHE,并且仅清除了40%。两项测试未显示出一致的结果,可能是因为它们描述了MHE的不同方面:CFF给出了MHE的星形细胞代谢状态以及致病方面的量度,而CRT则给出了复合关键性能的量度。对感觉刺激做出适当反应的能力。测试的选择取决于临床和科学护理以及患者研究所需的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号